Valuation: Cutera

Market Cap 7.12M 6.25M 5.76M 5.39M 10.11M 672M 10.32M 69.2M 26.78M 332M 26.75M 26.17M 1.15B P/E 2022
-10.1x
P/E 2023 -0.43x
Enterprise Value 295M 259M 239M 224M 419M 27.87B 428M 2.87B 1.11B 13.77B 1.11B 1.09B 47.76B EV / Sales 2022
3.89x
EV / Sales 2023 1.69x
Free-Float
-
Yield 2022 *
-
Yield 2023 -
3 years 0
Extreme 0.005
21.41
5 years 0
Extreme 0.005
74.38
10 years 0
Extreme 0.005
74.38
Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 60 2023-05-04
Investor Relations Contact - -
Director TitleAgeSince
Chairman 57 2023-06-30
Director/Board Member 67 2023-04-30
Director/Board Member 49 2023-05-18
Date Insider Type Main position Quantity % Market Cap.
25-02-12Tax

General Counsel

623 0.0031%
25-02-06Tax

Chief Executive Officer

4,620 0.0229%
25-01-31Tax

Chief Financial Officer

22 0.0001%

Financials

2022 2023
Net sales 252M 221M 204M 191M 358M 23.81B 366M 2.45B 949M 11.77B 948M 927M 40.8B 212M 186M 172M 161M 301M 20.03B 308M 2.06B 798M 9.9B 797M 780M 34.33B
Net income -82.34M -72.2M -66.55M -62.3M -117M -7.77B -119M -800M -309M -3.84B -309M -302M -13.31B -163M -143M -132M -123M -231M -15.36B -236M -1.58B -612M -7.59B -611M -598M -26.32B
Net Debt 115M 100M 92.63M 86.72M 163M 10.81B 166M 1.11B 431M 5.34B 430M 421M 18.53B 288M 253M 233M 218M 409M 27.2B 418M 2.8B 1.08B 13.44B 1.08B 1.06B 46.61B
Logo Cutera
Cutera, Inc. is a provider of aesthetic and dermatology solutions for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured Secret systems and consumables. It markets various system platforms, such as AviClear, enlighten, excel V/V+, excel HR, truSculpt, Secret PRO, Secret DUO Secret RF, xeo, and xeo+, each of which enables medical practitioners to perform procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. With its xeo platform, practitioners can purchase customized systems with a variety of the Company’s multi-technology applications. Each of the Company’s products consists of a control console and one or more hand pieces, depending on the model.
Employees
430
Sector
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. CUTR Stock